These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26941095)

  • 41. Interaction of programmed death-1 and programmed death-1 ligand-1 contributes to testicular immune privilege.
    Cheng X; Dai H; Wan N; Moore Y; Vankayalapati R; Dai Z
    Transplantation; 2009 Jun; 87(12):1778-86. PubMed ID: 19543053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The blockage signal for PD-L1/CD274 gene variants and their potential impact on lung carcinoma susceptibility.
    Sakran MI; Alalawy AI; Alharbi AA; El-Hefnawy ME; Alzahrani SM; Alfuraydi A; Alzuaibr FM; Zidan NS; Elsaid AM; Toraih EA; Elshazli RM
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111180. PubMed ID: 37939515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
    Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity.
    Gianchecchi E; Delfino DV; Fierabracci A
    Autoimmun Rev; 2013 Sep; 12(11):1091-100. PubMed ID: 23792703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An optimized protocol for the in vitro generation and functional analysis of human PD1/PD-L1 signal.
    Khedri M; Abnous K; Rafatpanah H; Ramezani M
    J Recept Signal Transduct Res; 2018 Feb; 38(1):31-36. PubMed ID: 29252078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelial Stromal PD-L1 (Programmed Death Ligand 1) Modulates CD8
    Bracamonte-Baran W; Gilotra NA; Won T; Rodriguez KM; Talor MV; Oh BC; Griffin J; Wittstein I; Sharma K; Skinner J; Johns RA; Russell SD; Anders RA; Zhu Q; Halushka MK; Brandacher G; Čiháková D
    Circ Heart Fail; 2021 Oct; 14(10):e007982. PubMed ID: 34555935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.
    Li W; Wang X; Chen R; Zhu H; Chen G; Sun X
    J Surg Res; 2012 Aug; 176(2):e79-87. PubMed ID: 22381170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.
    Heeger PS; Greenspan NS; Kuhlenschmidt S; Dejelo C; Hricik DE; Schulak JA; Tary-Lehmann M
    J Immunol; 1999 Aug; 163(4):2267-75. PubMed ID: 10438971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effector T cell function rather than survival determines extent and duration of hepatitis in mice.
    Vo M; Holz LE; Wong YC; English K; Benseler V; McGuffog C; Azuma M; McCaughan GW; Bowen DG; Bertolino P
    J Hepatol; 2016 Jun; 64(6):1327-38. PubMed ID: 26924452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of association between CTLA-4 and PDCD1 polymorphisms and acute rejection in German liver transplant recipients.
    Thude H; Schipler AD; Treszl A; Peine S; Koch M; Sterneck M; Nashan B
    Hum Immunol; 2013 Aug; 74(8):1041-5. PubMed ID: 23628397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses.
    de Mare-Bredemeijer EL; Mancham S; Verstegen MM; de Ruiter PE; van Gent R; O'Neill D; Tilanus HW; Metselaar HJ; de Jonge J; Kwekkeboom J; Hall SR; van der Laan LJ
    Stem Cells Dev; 2015 Jun; 24(12):1436-47. PubMed ID: 25744002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts.
    Miyagawa-Hayashino A; Tsuruyama T; Egawa H; Haga H; Sakashita H; Okuno T; Toyokuni S; Tamaki K; Yamabe H; Manabe T; Uemoto S
    Am J Pathol; 2007 Nov; 171(5):1499-508. PubMed ID: 17823283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host disease.
    Al-Chaqmaqchi H; Sadeghi B; Abedi-Valugerdi M; Al-Hashmi S; Fares M; Kuiper R; Lundahl J; Hassan M; Moshfegh A
    PLoS One; 2013; 8(4):e60367. PubMed ID: 23593203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.
    Blank C; Kuball J; Voelkl S; Wiendl H; Becker B; Walter B; Majdic O; Gajewski TF; Theobald M; Andreesen R; Mackensen A
    Int J Cancer; 2006 Jul; 119(2):317-27. PubMed ID: 16482562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complement C3F allotype synthesized by liver recipient modifies transplantation outcome independently from donor hepatic C3.
    Valero-Hervás DM; Sánchez-Zapardiel E; Castro MJ; Gallego-Bustos F; Cambra F; Justo I; Laguna-Goya R; Jiménez-Romero C; Moreno E; López-Medrano F; San Juan R; Fernández-Ruiz M; Aguado JM; Paz-Artal E
    Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27801525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PD-1-PD-L1 immune-checkpoint blockade in malignant lymphomas.
    Wang Y; Wu L; Tian C; Zhang Y
    Ann Hematol; 2018 Feb; 97(2):229-237. PubMed ID: 29128997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated programmed cell death-1 protein/ligand (PD-1/PD-L1) and variants are associated with susceptibility to multiple myeloma: a case-control study in the Chinese cohort.
    Yang J; Meng L; Yang Y; Gao H; Jiang H
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(3):230-248. PubMed ID: 37688463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of the relationships between IL-23R, IL-17, IL-21 polymorphisms and serum level of IL-17, IL-21 with acute graft rejection in iranian liver transplant recipients.
    Karimi MH; Hejr S; Geramizadeh B; Nikeghbalian S; Kamali-Sarvestani E; Yaghobi R
    Immunol Invest; 2014; 43(1):69-85. PubMed ID: 24313807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma.
    Moksud N; Wagner M; Pawełczyk K; Porębska I; Muszczyńska-Bernhard B; Kowal A; Wiśniewski A; Kosacka M; Kończak J; Karpiński P; Frydryk D; Andrzejczak A; Karabon L; Kuśnierczyk P; Jasek M
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6381-6390. PubMed ID: 36759392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PD-L1 cellular nanovesicles carrying rapamycin inhibit alloimmune responses in transplantation.
    Yang M; Xu Z; Yan H; Tsai HI; Su D; Yan F; Lu Q; Feng J; Zeng W; Xi L; Zha H; Ling Y; He C; Wu Y; Xu X; Zheng G; Liu G; Chen H; Cheng F
    Biomater Sci; 2021 Feb; 9(4):1246-1255. PubMed ID: 33367372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.